Conference Expired

BDAB 2025 : 6th International Conference on Big Data and Blockchain

In Person Switzerland January 18-19, 2025
Visit Website

About the Conference

6th International Conference on Big Data and Blockchain (BDAB 2025)

January 18 ~ 19, 2025, Zurich, Switzerland

Hybrid -- Registered authors can present their work online or face to face.

Scope & Topics

6th International Conference on Big Data and Blockchain (BDAB 2025) will act as a major forum for the presentation of innovative ideas, approaches, developments, and research projects in the areas of Big Data and Blockchain. It will also serve to facilitate the exchange of information between researchers and industry professionals to discuss the latest issues and advancement in the area of Big Data and Blockchain.


Authors are solicited to contribute to the conference by submitting articles that illustrate research results, projects, surveying works and industrial experiences that describe significant advances in the following areas, but are not limited to

Topics of interest include, but are not limited to, the following

Paper Submission

Authors are invited to submit papers through the conference Submission System by December 14, 2024. Submissions must be original and should not have been published previously or be under consideration for publication while being evaluated for this conference. The proceedings of the conference will be published by Computer Science Conference Proceedings (H index 43) in Computer Science & Information Technology (CS & IT) series (Confirmed).

Selected papers from BDAB 2024, after further revisions, will be published in the special issue of the following journals.

Important Dates

Submission Deadline: December 14, 2024
Authors Notification: December 30, 2024
Final Manuscript Due: January 03, 2025

Co - Located Event

***** The invited talk proposals can be submitted to [email protected]

Topics of Interest

3 topics

Research papers are invited in, but not limited to, the following areas:

Comments

Share context, clarifications, or discussion about this CFP.

Please sign in to leave a comment. Sign in

No comments yet. Be the first to start the discussion.